| May 26, 2014
| 5:13 PM
While U.S. and British markets were closed for holidays Monday, stocks rose in Europe.
A benchmark of European equities climbed to a six-year high, while Italian and Spanish bonds advanced as policymakers said they would take steps to support economic...
| May 18, 2014
Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina.
Maryland officials don't want this state to join that list.
After Pfizer declared its desire to buy AstraZeneca — which...
| May 5, 2014
| 12:17 PM
Pharmaceutical giant Pfizer Inc. reported its first quarter earnings fell 15% as the company struggled with expiring patents and increasing competition from generic drugs.
The disappointing news added urgency to the New York company's efforts to acquire...
| May 8, 2014
| 4:34 PM
Gov. Martin O'Malley and Delaware Gov. Jack Markell sent a joint letter to Pfizer Thursday expressing concerns about its proposed $106 billion acquisition of pharmaceutical firm AstraZeneca, which employs thousands in both states.
The governors said...
| Apr 29, 2014
| 12:22 PM
Biotechnology company MedImmune said Tuesday it has expanded a bioresearch collaboration it started with the University of System of Maryland.
The Gaithersburg company, a development arm of AstraZeneca, started the partnership with the University of...
| Jan 8, 2014
| 6:45 PM
The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name...
| Nov 14, 2013
| 4:38 PM
Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...
| Sep 26, 2011
| 4:05 AM
CHICAGO (Reuters) - Genetic differences could explain why some 40 percent of people with asthma do not respond to inhaled steroids used to achieve long-term asthma control.
U.S. researchers have found that asthma patients who inherited two copies of a...
| Sep 27, 2011
At least three dozen doctors in Illinois received payments and perks exceeding $100,000 from drug companies between 2009 and early 2011, according to an updated database that now includes information from a dozen pharmaceutical firms.
Doctors in the...
| Oct 25, 2011
| 2:21 PM
NEW YORK (Reuters Health) - One class of drugs used to prevent wheezing and shortness of breath in people with asthma may increase kids' risk of being hospitalized for an asthma attack, according to a new analysis from the U.S. Food and Drug...
| Feb 21, 2013
| 11:27 AM
Saint Agnes Hospital will work with local churches to screen for heart disease, using a $244,455 grant from The AstraZeneca HealthCare Foundation.
The hospital announced Thursday that it had received the award.
The screening program will focus on...